Brad A Amendt

Brad A Amendt is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of biomedical research, particularly in the generation of epithelial cells and bone regeneration. With a total of 5 patents, his work has the potential to impact tissue repair and regenerative medicine.

Latest Patents

One of his latest patents focuses on methods to generate epithelial cells. This invention provides a method of generating a re-programmed differentiated epithelial cell by contacting a non-stem somatic cell with a de-differentiation agent to form a de-differentiated cell. The process continues with transfecting the de-differentiated cell with an expression cassette that includes a promoter linked to a nucleic acid encoding a conversion agent. Additionally, the invention outlines a method of generating re-programmed differentiated epithelial cells that can be used to repair or regenerate tissue in vivo. Another significant patent involves microRNA-200 based approaches for modulating bone formation inhibition and bone regeneration. This invention utilizes microRNA (miR)-200a to inhibit ossification and promote bone formation.

Career Highlights

Brad A Amendt is affiliated with the University of Iowa Research Foundation, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential applications in medical science and regenerative therapies.

Collaborations

He has collaborated with notable colleagues such as Thad Sharp and Aliasger Karimjee Salem, contributing to the advancement of research in their respective fields.

Conclusion

Brad A Amendt's innovative work in generating epithelial cells and modulating bone formation showcases his commitment to advancing biomedical research. His contributions have the potential to significantly impact tissue repair and regenerative medicine.